EL SEGUNDO, Calif.--(BUSINESS WIRE)--EPC announces its Phase-14 Reliability Report, documenting the strategy used to achieve a remarkable field reliability record. The rapid adoption of GaN devices in ...
Tenax Therapeutics (TENX) is in a very good position as far as its drug development plan goes for its drug levosimendan. That's because it is already in the process of running the ongoing phase 3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback